UBS has given British American Tobacco (BAT) a "Neutral" rating and a target price of 3000 pence after the release of an interim report.
Analyst Faham Baig believes that BAT's outlook will improve in the coming year, although his projections for operating earnings growth in 2025 are lower than the consensus among analysts.
The report suggests that BAT has the potential to improve its financial performance, despite the analyst's cautious view on earnings estimates.
The findings were published on December 11, 2024, and reflect UBS's ongoing assessment of the tobacco sector and BAT's position within it.